BMP-4 treatment was shown to significantly elevate blood pressure and lead to endothelial dysfunction by increasing the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in mice (Miriyala et al., 2006). Here, BMP4 is linked to endothelial dysfunction.